Pharmacovigilance in the field of addiction: challenges and emerging solutions
Expert Review of Clinical Pharmacology · 02.12.2025 · 18 (12) · 989-1003
DOI: 10.1080/17512433.2025.2600414 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 09.12.2025. Verfasst von Maryse Lapeyre-Mestre und 3 weiteren Autor:innen. Beteiligte Einrichtung: CEIP-Addictovigilance, Service de Pharmacologie Médicale et Clinique, CHU de Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Pharmacovigilance, Substance-Related Disorders, Adverse Drug Reaction Reporting Systems, Prescription Drug Misuse. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 139 Literaturangaben.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
INTRODUCTION: Monitoring the safety of drugs regarding their potential for misuse falls within the scope of international conventions on narcotic and psychotropic drugs. In the U.S. a surveillance approach based on multiple sources has been implemented for decades and identified the opioid epidemic in the early 2000s. In Europe, this monitoring is carried out by the European Union Drugs Agency (EUDA) for substance abuse and by the European Medicines Agency (EMA) through pharmacovigilance activities for substances for therapeutic use. AREAS COVERED: Due to the hidden nature of prescription drug misuse, spontaneous pharmacovigilance reporting is rarely sufficient to quantify this complex phenomenon. This narrative review presents examples of a multisource approach based on a PubMed literature search using the terms 'pharmacovigilance' and 'addiction,' 'drug abuse,' or 'drug misuse.' These examples mainly concern the U.S. and the addictovigilance monitoring system in France. EXPERT OPINION: Because of the constant changes in the drug misuse phenomenon and the effectiveness of addictovigilance in addressing it, other countries should strongly consider adapting this approach (with the necessary adaptations) into their national monitoring systems and adopting the addictovigilance terminology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CEIP-Addictovigilance, Service de Pharmacologie Médicale et Clinique, CHU de Toulouse, Toulouse, France.
- Pharmacology in Population, Cohorts, Biobanks (PEPSS Research Team), CIC 1436, INSERM & Toulouse University, Toulouse, France.
- UMR 1106, INS, INSERM, Aix-Marseille University, Marseille, France.
- CEIP-Addictovigilance, Department of Clinical Pharmacology and Drug Surveillance, Marseille University Hospital, Marseille, France.
- UMR 5169, CRCA, CNRS, Toulouse University, Toulouse, France.
- UMR 1295, CERPOP, INSERM, Toulouse University, Toulouse, France.
ORCID-Profile: Maryse Lapeyre-Mestre, Joëlle Micallef, Romain Hacquet, Emilie Jouanjus
Zitieren
APA
Lapeyre-Mestre, M., Micallef, J., Hacquet, R., & Jouanjus, E. (2025). Pharmacovigilance in the field of addiction: challenges and emerging solutions. Expert Review of Clinical Pharmacology, 18(12), 989-1003. https://doi.org/10.1080/17512433.2025.2600414
Vancouver
Lapeyre-Mestre M, Micallef J, Hacquet R, Jouanjus E. Pharmacovigilance in the field of addiction: challenges and emerging solutions. Expert Review of Clinical Pharmacology. 2025;18(12):989-1003. doi:10.1080/17512433.2025.2600414
BibTeX
@article{LapeyreMestre2025,
author = {Lapeyre-Mestre, Maryse and Micallef, Joëlle and Hacquet, Romain and Jouanjus, Emilie},
title = {Pharmacovigilance in the field of addiction: challenges and emerging solutions},
journal = {Expert Review of Clinical Pharmacology},
year = {2025},
volume = {18},
number = {12},
pages = {989--1003},
doi = {10.1080/17512433.2025.2600414}
}
EUVIMED